BioCentury
ARTICLE | Company News

Enzon Inc. deal

September 12, 1994 7:00 AM UTC

Enzon Inc. (ENZN) Rhone-Poulenc Rorer Inc. received an exclusive license in Canada to market ENZN's Oncaspar (pegaspargase), a treatment for acute lymphoblastic leukemia (ALL) in patients who requir...